CARLSBAD, Calif., Jan. 21, 2014 /PRNewswire/ -- Life Technologies
Corporation (NASDAQ: LIFE) today announced the availability of the
only USDA-licensed, real-time PCR test to detect Tritrichomonas
foetus (T. foetus) – a sexually transmitted disease in cattle
that leads to early embryonic losses and infertility, resulting in
significant economic impact to the cattle industry due to open
(non-pregnant) and late-calving cows.
The VetMAX-Gold Trich Detection Kit provides veterinary
diagnostic laboratories with a test that provides highly sensitive
and specific results through real-time PCR amplification of T.
foetus DNA. Accurate testing to identify positive bulls is the
only way to prevent the spread of Trichomoniasis disease prior to
cows being exposed to bulls. Infected bulls do not show any outward
signs of infection.
"USDA licensing ensures increased confidence in accurate testing
results that are critical for the cattle industry to effectively
manage bovine Trichomoniasis," said Kirk
Adams, Animal Health Global Product Management
Leader, Life Technologies. "Validating the sensitivity
and specificity of this diagnostic test through the USDA approval
process shows Life's commitment to offer quality products and
invest in the research needed to secure this license."
The approval of the VetMAX-Gold Trich Detection Kit is based on
the successful completion of the USDA's stringent review process to
ensure effectiveness of the real-time PCR test, manufactured in our
USDA licensed and inspected production facility. Veterinary
diagnosticians have historically relied on Life Technologies'
molecular reagents and instrumentation to detect and control animal
diseases. However, the USDA-licensed product now provides them with
a federally approved diagnostic test for Trichomoniasis containing
all the necessary reagents and controls in a single detection
kit.
An alternative to the culture testing method, real-time PCR
diagnostic methodology results in a more convenient and accurate
test from one sample run in comparison to three culture tests
spanning a three-week period. Additionally, because of the
sensitivity of real-time PCR, samples can be pooled for greater
test cost efficiencies. The VetMAX-Gold Trich Detection Kit is
licensed with a USDA label claim for pooling up to five
samples.
"Life Technologies is committed to the animal health industry by
providing next generation molecular tools that help veterinary
laboratory diagnosticians more accurately test for diseases of
economic impact," said Adams. "Real-time PCR has the potential to
become a new standard for T. foetus testing and will help
multiple states find common ground for the harmonization of using
the best diagnostic technology solution to manage Trichomoniasis
within and between states."
About Life Technologies
Life Technologies Corporation
(NASDAQ: LIFE) is a global biotechnology company that is committed
to providing the most innovative products and services to leading
customers in the fields of scientific research, genetic analysis
and applied sciences. With a presence in more than 180 countries,
the company's portfolio of 50,000 end-to-end solutions is secured
by more than 5,000 patents and licenses that span the entire
biological spectrum – scientific exploration, molecular
diagnostics, 21st century forensics, regenerative
medicine and agricultural research. Life Technologies has
approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our
anticipated results that involve risks and uncertainties. Some of
the information contained in this press release, including, but not
limited to, statements as to industry trends and Life Technologies'
plans, objectives, expectations and strategy for its business,
contains forward-looking statements that are subject to risks and
uncertainties that could cause actual results or events to differ
materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical
fact are forward-looking statements. When used, the words
"believe," "plan," "intend," "anticipate," "target," "estimate,"
"expect" and the like, and/or future tense or conditional
constructions ("will," "may," "could," "should," etc.), or similar
expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ
materially from those in the forward-looking statements are
detailed in filings made by Life Technologies with the Securities
and Exchange Commission. Life Technologies undertakes no obligation
to update or revise any such forward-looking statements to reflect
subsequent events or circumstances.
Media Contact:
Dean
Loftis
Account Supervisor
McCormick Company
(903) 564-6545
SOURCE Life Technologies Corporation